Recent Finacing
Recent Raise
āshibio is a biotech developing MMP‑9–targeted therapeutics for bone and connective tissue disorders, licensed andecaliximab from Gilead for FOP with an FDA‑cleared IND and planned Phase 2/3 trial.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors